Direct measurement is required for accurate assessment of body composition during therapy for acute lymphoblastic leukemia: A report from the T2020-003 IDEAL2 trial
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Etan Orgel, Yueh-Yun Chi, Jemily Malvar, Rubi Buxton, Mackenzie Frederick, Hannah Williams, Tamara Miller, Brent Wood, Christina Dieli-Conwright, Karen Rabin, Susan Rheingold, Robin Norris, Elllynore Florendo, Lisa Hartman, Mallorie Heneghan, Tamra Slone, Joel Kaplan, Ellen Chang, Bill Chang, Deepa Bhojwani, Alan Wayne, Sarah Tasian, Steven Mittelman
Institutions: University of Southern California, Children's Hospital of Los Angeles, Children's Hospital Colorado, Children's Hospital of Philadelphia, Children's Healthcare of Atlanta, Dana-Farber Cancer Institute, University of California, San Francisco, Cincinnati Children's Hospital Medical Center, Primary Children's Hospital, The University of Texas Southwestern Medical Center, Carolinas Medical Center, Oregon Health & Science University, University of California, Los Angeles
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417004276
Cites:
Cited by:
Related to: